British Columbia Mandates Supervision for Prescribed Drug Use

On March 15, 2023, British Columbia implemented a new requirement mandating that participants in the Prescribed Alternatives Program consume their medications under the supervision of a pharmacist or another regulated health professional. This initiative is part of the province’s ongoing efforts to combat overdose deaths by replacing illicit drugs with safer, regulated alternatives such as opioids and stimulants.

The Prescribed Alternatives Program, introduced in March 2020, aims to reduce the risks associated with unregulated drug use. By ensuring that medications are consumed in a supervised setting, officials believe it will help diminish the potential for the resale or sharing of prescribed drugs in the street market. This decision follows reports of significant drug diversion from the program, with allegations that approximately 60 pharmacies were involved in illegal activities.

In the wake of these developments, harm reduction expert Guy Felicella expressed concerns about the implications of the new supervision requirement. He noted that while there are issues surrounding drug diversion, it is not as widespread as some politicians suggest. “If the program needs tweaking, then we tweak it. It’s a very valuable tool for a lot of people,” Felicella stated. He emphasized that the program itself has not been linked to increasing deaths but rather pointed to the dangers posed by the unregulated drug supply.

Felicella raised concerns that the witnessed-consumption model could hinder individuals who have successfully transitioned from unregulated drugs to prescribed medications. He questioned the practicality of requiring patients to visit a pharmacy every day for their medication, suggesting that such requirements could discourage individuals from seeking help.

“I’m fine with the changes that are made for people diverting the substances, I’m not fine with the changes that are made for the people that aren’t,” Felicella explained to CityNews. He warned that removing stability from those already using prescribed substances could lead them back to the toxic street drug market.

The Ministry of Health has acknowledged the effectiveness of the Prescribed Alternatives Program, highlighting its role in keeping people alive by offering a safer alternative to the poisoned drug supply. However, the ministry also recognizes that there are individuals misusing the program.

Conservative MLA Claire Rattee, who has publicly shared her experiences as a recovered addict, supported the new supervision requirement. Rattee described the program as potentially detrimental, stating that had it existed during her struggles, it might have prevented her from seeking treatment. “If this program existed before I went to treatment, I know myself well enough to know that the likelihood is I would still be homeless in the downtown east side doing drugs, if not dead,” she said.

As the B.C. Coroners Service recently reported an eight percent decrease in deaths from unregulated drug toxicity over the past year, the effectiveness of the Prescribed Alternatives Program remains a topic of debate. The ongoing scrutiny of the program illustrates the complexities of addressing drug addiction and the urgent need for effective harm reduction strategies.

In the face of rising concerns about drug diversion and the safety of prescribed alternatives, British Columbia’s approach represents a critical step in balancing the need for harm reduction with the imperative of safeguarding public health.